JOSEPH EDELMAN Insider Trading $XTLB XTL BIOPHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH EDELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH EDELMAN. JOSEPH EDELMAN is 10% Owner in MACROCHEM CORP ($MCHM) and 10% Owner in PENWEST PHARMACEUTICALS CO ($PPCO) and 10% Owner in XTL BIOPHARMACEUTICALS LTD ($XTLB) and 10% Owner in OPTIMER PHARMACEUTICALS INC ($OPTR).
JOSEPH EDELMAN in XTL BIOPHARMACEUTICALS LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOSEPH EDELMAN: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 03 2008
$XTLB Market Capitalization: $8.04M
$XTLB Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOSEPH EDELMAN in XTL BIOPHARMACEUTICALS LTD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MCHM, OPTR, PPCO, XTLB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.15 | 299,570 | 45,774 | 0 | 299.6 K to 0 (-100.00 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.15 | 400,000 | 61,120 | 299,570 | 699.6 K to 299.6 K (-57.18 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.14 | 1,943,250 | 273,804 | 699,570 | 2.6 M to 699.6 K (-73.53 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.16 | 400,000 | 64,560 | 2,642,820 | 3 M to 2.6 M (-13.15 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.16 | 29,740 | 4,729 | 3,042,820 | 3.1 M to 3 M (-0.97 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.15 | 9,600,000 | 1,466,880 | 20,580,260 | 30.2 M to 20.6 M (-31.81 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.15 | 2,696,450 | 412,018 | 30,180,260 | 32.9 M to 30.2 M (-8.20 %) |
| Dec 03 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Sell | S | 0.14 | 24,681,360 | 3,477,604 | 32,876,710 | 57.6 M to 32.9 M (-42.88 %) |
| Jun 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.23 | 2,040 | 6,589 | 3,072,560 | 3.1 M to 3.1 M (+0.07 %) |
| Jun 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.23 | 48,960 | 158,141 | 57,558,070 | 57.5 M to 57.6 M (+0.09 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.36 | 1,340 | 4,502 | 3,070,520 | 3.1 M to 3.1 M (+0.04 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.43 | 4,000 | 13,720 | 3,069,180 | 3.1 M to 3.1 M (+0.13 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 8,000 | 25,200 | 3,065,180 | 3.1 M to 3.1 M (+0.26 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 4,000 | 13,480 | 3,057,180 | 3.1 M to 3.1 M (+0.13 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.36 | 32,260 | 108,394 | 57,509,110 | 57.5 M to 57.5 M (+0.06 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.43 | 96,000 | 329,280 | 57,476,850 | 57.4 M to 57.5 M (+0.17 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 192,000 | 604,800 | 57,380,850 | 57.2 M to 57.4 M (+0.34 %) |
| Jun 11 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 96,000 | 323,520 | 57,188,850 | 57.1 M to 57.2 M (+0.17 %) |
| Jun 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.99 | 1,000 | 2,990 | 3,053,180 | 3.1 M to 3.1 M (+0.03 %) |
| Jun 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.03 | 16,040 | 48,601 | 3,052,180 | 3 M to 3.1 M (+0.53 %) |
| Jun 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.99 | 24,000 | 71,760 | 57,092,850 | 57.1 M to 57.1 M (+0.04 %) |
| Jun 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.03 | 384,690 | 1,165,611 | 57,068,850 | 56.7 M to 57.1 M (+0.68 %) |
| May 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.88 | 2,000 | 7,760 | 3,036,140 | 3 M to 3 M (+0.07 %) |
| May 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.75 | 4,200 | 15,750 | 3,034,140 | 3 M to 3 M (+0.14 %) |
| May 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.88 | 48,000 | 186,240 | 56,683,890 | 56.6 M to 56.7 M (+0.08 %) |
| May 06 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.75 | 100,800 | 378,000 | 56,635,890 | 56.5 M to 56.6 M (+0.18 %) |
| May 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.74 | 5,130 | 19,205 | 3,029,940 | 3 M to 3 M (+0.17 %) |
| May 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.54 | 9,160 | 32,407 | 3,024,810 | 3 M to 3 M (+0.30 %) |
| May 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.74 | 123,240 | 461,374 | 56,535,090 | 56.4 M to 56.5 M (+0.22 %) |
| May 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.54 | 220,080 | 778,621 | 56,441,850 | 56.2 M to 56.4 M (+0.39 %) |
| Apr 16 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.56 | 10,000 | 35,579 | 3,015,650 | 3 M to 3 M (+0.33 %) |
| Apr 16 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.58 | 90,000 | 322,011 | 56,191,770 | 56.1 M to 56.2 M (+0.16 %) |
| Apr 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.16 | 10,000 | 31,625 | 3,005,650 | 3 M to 3 M (+0.33 %) |
| Apr 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.16 | 10,050 | 31,783 | 2,995,650 | 3 M to 3 M (+0.34 %) |
| Apr 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.16 | 190,950 | 603,879 | 56,101,770 | 55.9 M to 56.1 M (+0.34 %) |
| Apr 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.16 | 90,000 | 284,625 | 55,910,820 | 55.8 M to 55.9 M (+0.16 %) |
| Apr 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.90 | 1,250 | 3,623 | 2,985,600 | 3 M to 3 M (+0.04 %) |
| Apr 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.90 | 23,750 | 68,837 | 55,820,820 | 55.8 M to 55.8 M (+0.04 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.30 | 11,900 | 39,327 | 2,908,700 | 2.9 M to 2.9 M (+0.41 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.31 | 30,000 | 99,351 | 2,896,800 | 2.9 M to 2.9 M (+1.05 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.28 | 25,200 | 82,568 | 2,866,800 | 2.8 M to 2.9 M (+0.89 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 30,000 | 94,500 | 2,841,600 | 2.8 M to 2.8 M (+1.07 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.25 | 30,000 | 97,368 | 2,811,600 | 2.8 M to 2.8 M (+1.08 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 94,000 | 317,090 | 55,205,500 | 55.1 M to 55.2 M (+0.17 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.38 | 138,180 | 467,090 | 55,111,500 | 55 M to 55.1 M (+0.25 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.35 | 272,600 | 913,237 | 54,973,320 | 54.7 M to 55 M (+0.50 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 141,000 | 474,620 | 54,700,720 | 54.6 M to 54.7 M (+0.26 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.30 | 107,100 | 353,944 | 54,559,720 | 54.5 M to 54.6 M (+0.20 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.31 | 470,000 | 1,556,499 | 54,452,620 | 54 M to 54.5 M (+0.87 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.28 | 394,800 | 1,293,562 | 5,398,260 | 5 M to 5.4 M (+7.89 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 470,000 | 1,480,500 | 53,587,820 | 53.1 M to 53.6 M (+0.88 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.25 | 470,000 | 1,525,432 | 53,117,820 | 52.6 M to 53.1 M (+0.89 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.12 | 6,650 | 20,749 | 2,984,350 | 3 M to 3 M (+0.22 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.32 | 12,000 | 39,856 | 2,977,700 | 3 M to 3 M (+0.40 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.33 | 15,780 | 52,566 | 2,965,700 | 2.9 M to 3 M (+0.53 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 6,000 | 20,240 | 2,949,920 | 2.9 M to 2.9 M (+0.20 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.38 | 8,820 | 29,814 | 2,943,920 | 2.9 M to 2.9 M (+0.30 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.37 | 9,000 | 30,295 | 2,935,100 | 2.9 M to 2.9 M (+0.31 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.35 | 17,400 | 58,292 | 2,926,100 | 2.9 M to 2.9 M (+0.60 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.12 | 156,350 | 487,843 | 55,797,070 | 55.6 M to 55.8 M (+0.28 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.32 | 188,000 | 624,404 | 55,640,720 | 55.5 M to 55.6 M (+0.34 %) |
| Mar 20 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.33 | 247,220 | 823,539 | 55,452,720 | 55.2 M to 55.5 M (+0.45 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.74 | 60,000 | 224,268 | 2,781,600 | 2.7 M to 2.8 M (+2.20 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.65 | 9,020 | 32,893 | 2,721,600 | 2.7 M to 2.7 M (+0.33 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.86 | 39,300 | 151,824 | 2,712,580 | 2.7 M to 2.7 M (+1.47 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.73 | 15,600 | 58,146 | 2,673,280 | 2.7 M to 2.7 M (+0.59 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.65 | 141,440 | 515,789 | 52,647,820 | 52.5 M to 52.6 M (+0.27 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.74 | 940,000 | 3,513,532 | 52,506,380 | 51.6 M to 52.5 M (+1.82 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.73 | 244,400 | 910,952 | 51,566,380 | 51.3 M to 51.6 M (+0.48 %) |
| Mar 19 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.86 | 615,700 | 2,378,572 | 51,321,980 | 50.7 M to 51.3 M (+1.21 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.94 | 34,200 | 134,700 | 2,657,680 | 2.6 M to 2.7 M (+1.30 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.99 | 6,640 | 26,490 | 2,623,480 | 2.6 M to 2.6 M (+0.25 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.98 | 18,000 | 71,656 | 2,616,840 | 2.6 M to 2.6 M (+0.69 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.94 | 535,800 | 2,110,302 | 50,706,280 | 50.2 M to 50.7 M (+1.07 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.98 | 282,000 | 1,122,614 | 50,170,480 | 49.9 M to 50.2 M (+0.57 %) |
| Mar 10 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.99 | 104,060 | 415,137 | 49,888,480 | 49.8 M to 49.9 M (+0.21 %) |
| Jan 08 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 12,000 | 37,787 | 1,676,500 | 1.7 M to 1.7 M (+0.72 %) |
| Jan 08 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.10 | 15,000 | 46,500 | 1,664,500 | 1.6 M to 1.7 M (+0.91 %) |
| Jan 08 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.15 | 188,000 | 591,993 | 35,468,270 | 35.3 M to 35.5 M (+0.53 %) |
| Jan 08 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 3.10 | 235,000 | 728,500 | 35,280,270 | 35 M to 35.3 M (+0.67 %) |
| Jan 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.89 | 78,000 | 225,420 | 1,649,500 | 1.6 M to 1.6 M (+4.96 %) |
| Jan 04 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.89 | 1,222,000 | 3,531,580 | 35,045,270 | 33.8 M to 35 M (+3.61 %) |
| Jan 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.74 | 69,000 | 188,750 | 1,571,500 | 1.5 M to 1.6 M (+4.59 %) |
| Jan 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.69 | 48,000 | 129,226 | 1,502,500 | 1.5 M to 1.5 M (+3.30 %) |
| Jan 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.74 | 1,081,000 | 2,957,076 | 33,823,270 | 32.7 M to 33.8 M (+3.30 %) |
| Jan 02 2008 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.69 | 752,000 | 2,024,534 | 32,742,270 | 32 M to 32.7 M (+2.35 %) |
| Dec 31 2007 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.60 | 18,000 | 46,717 | 1,454,500 | 1.4 M to 1.5 M (+1.25 %) |
| Dec 31 2007 | XTLB | XTL BIOPHARMACEUTI ... | EDELMAN JOSEPH | 10% Owner | Buy | P | 2.60 | 282,000 | 731,903 | 31,990,270 | 31.7 M to 32 M (+0.89 %) |
Page: 1